Patents by Inventor John Seung-Hoon Yi

John Seung-Hoon Yi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION TREATMENTS IN DIFFICULT TO TREAT PATIENTS WITH ADVANCED AND/OR METASTATIC TROP-2 OVEREXPRESSING CANCERS
    Publication number: 20240139196
    Abstract: This invention is in the area of improved combination treatments for a select group of hard-to-treat cancer patients, including, for example, those with advanced/metastatic triple negative breast cancer (TNBC), recurrent or metastatic urothelial cancer (mUC), or a Trop-2 overexpressing cancer such as non-small cell lung cancer (NSCLC), wherein the improved combination includes the use of trilaciclib and sacituzumab govitecan, and provides increased overall survival and/or reduced toxicity.
    Type: Application
    Filed: December 22, 2023
    Publication date: May 2, 2024
    Applicant: G1 Therapeutics, Inc.
    Inventors: Andrew Beelen, Rajesh Kumar Malik, John Seung-Hoon Yi, Curt Douglas Wolfgang